• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; system, appendage closure, left atrial

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; system, appendage closure, left atrial Back to Search Results
Model Number M635WU50310
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Codes Abdominal Pain (1685); Chest Pain (1776); Encephalopathy (1833); Hematoma (1884); High Blood Pressure/ Hypertension (1908); Low Blood Pressure/ Hypotension (1914); Ischemia (1942); Muscle Weakness/Atrophy (1967); Paralysis (1997); Renal Failure (2041); Dizziness (2194); Numbness (2415); Spinal Cord Injury (2432); Thrombosis/Thrombus (4440); Mitral Valve Insufficiency/ Regurgitation (4451); Back pain (4895)
Date of Event 08/13/2026
Type of Reportable Event Death
Event or Problem Description
Reported via literature article it was reported that death occurred.A 67-year-old man underwent successful transfemoral left atrial appendage occlusion (laao) with a 31mm watchman flx closure device with transesophageal echocardiography (tee) guidance.Multiple angles were used to evaluate the left atrial appendage (laa) dimensions, with the widest ostium measured at 22 mm.The implant satisfied manufacturer position, anchor, size, and seal (pass) criteria.Immediate post implant tee confirmed appropriate closure device position, stable anchoring, adequate seal, and closure device compression of 19 to 29 percent with no peri device leak on color doppler assessment.No procedural complications occurred, and the patient was observed overnight, as per institutional protocol.The patient was discharged on dual antiplatelet therapy and instructed to avoid strenuous activity for two (2) weeks.Eighteen days later, while shoveling snow, the patient developed sudden-onset chest and back pain followed by bilateral lower extremity paralysis.Computed tomography (ct) revealed complete mid abdominal aortic occlusion from embolization of the laao closure device.Using a non-boston scientific (bsc) grasping forceps, the embolized closure device was captured and successfully retrieved into the non-bsc sheath and removed.Postretrieval angiography demonstrated no aortic dissection or contrast extravasation, and there was successful restoration of arterial flow to the kidneys, viscera, and lower extremities.Despite emergent endovascular retrieval and restoration of aortic flow, the patient developed fatal distributive shock from severe ischemia-reperfusion injury.The patient died within 48 hours of presentation.
 
Additional Manufacturer Narrative
B2: estimated as 08/13/26 as the published date for the article is noted as august 13, 2026, and the death date is unknown.B3: estimated as 08/13/26 as the published date for the article is noted as august 13, 2026, and the event date is unknown.D4: detailed product information was not provided to bsc.We completed a good faith effort to obtain the information.Because the product is unknown at this time, we are unable to provide the complete udi and other product specific information.If additional details become available, a supplemental report will be submitted.Literature citation: mackey, r., miller, a., palatnic, l.Et al.(2026) delayed aortic embolization of a left atrial appendage occlusion device: implications for risk-stratified postprocedural management.J am coll cardiol case rep.Null2026, 0 (0).Https://doi.Org/10.1016/j.Jaccas.2026.109756.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX?
Common Device Name
system, appendage closure, left atrial
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
Boston Scientific Corporation
ballybrit business park
galway
EI  
Manufacturer Contact
mary crawford
4100 hamline ave n
arden hills, MN 55112
+1(651)440-0979
MDR Report Key50951585
Report Number2124215-2026-52105
Device Sequence Number15859081
Product Code NGV
UDI-Device Identifier08714729860518
UDI-Public(01)08714729860518
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Literature,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM635WU50310
Device Catalogue NumberM635WU50310
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/29/2026
Initial Report FDA Received Date09/30/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention; Death; Other;
Patient Age67 YR
Patient SexMale
-
-